Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Thomas, PHD, FRACP
Omico; UNSW Sydney
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Border Medical Oncology Research Unit
Albury, New South Wales, Australia
Christopher Steer, MBBS, FRACPRecruiting - Ramsay Health Care Australia Pty Ltd Trading As the Border Cancer Hospital
Albury, New South Wales, Australia
Christopher Steer, MBBS, FRACPRecruiting - Coffs Harbour Health Campus
Coffs Harbour, New South Wales, Australia
Karen Briscoe, MDRecruiting - Orange Base Hospital
Orange, New South Wales, Australia
Recruiting - Port Macquarie Base Hospital
Port Macquarie, New South Wales, Australia
Stephen Begbie, MDRecruiting - Cairns Hospital
Cairns, Queensland, Australia
Megan Lyle, MDNot, yet, recruiting - Rockhampton Hospital
Rockhampton, Queensland, Australia
Bahram Forouzesh, MDNot, yet, recruiting - Toowoomba Hospital
Toowoomba, Queensland, Australia
Khageshwor Pokharel, MDNot, yet, recruiting - Townsville Hospital
Townsville, Queensland, Australia
Jun B Kong, MDRecruiting - Royal Hobart Hospital
Hobart, Tasmania, Australia
Rosemary Harrup, MDRecruiting - Bendigo Health
Bendigo, Victoria, Australia
Sam Harri, MDRecruiting - Barwon Health
Geelong, Victoria, Australia
David Campbell, MDRecruiting - Fiona Stanley Hospital
Perth, Western Australia, Australia
Wei-Sen Lam, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Dec 2023
- Primary completion
- 1 May 2026
- Completion
- 1 Nov 2028
- Last update posted
- 15 Nov 2024
- Registered enrollment
- 96
- Registry id
- NCT06003621
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.